Elucid is a Boston-based medical technology company using uniquely interpretable and validated AI to provide physicians with a cost-effective means to optimize treatment decisions for patients with cardiovascular disease. Advanced clinical insight from Elucid equips physicians with critical information designed to enable precision medicine. Elucid is the first FDA-Cleared and CE-marked non-invasive software to quantify atherosclerotic plaque characteristics compared to histopathology, including Lipid Rich Necrotic Core. The company has published studies for its derivation of fractional flow reserve (FFRct) based on the vasodilative capacity of the vessel wall and estimation of coding and non-coding RNA transcripts (“Virtual Transcriptomics”). This unique information informs improved treatment decisions by physicians leading to better patient outcomes, improved quality of care, and reduced healthcare costs. The Elucid software is available for commercial use in the U.S. and Europe
MY01 is a state-of-the-art medical device geared towards aiding in the detection of Compartment Syndrome (CS); a limb-threatening muscle condition that occurs within 48 hours following trauma. Currently, ACS is diagnosed based on subjective and unreliable outcomes like pain (known as 6 P`s), which when present cannot confirm the diagnosis in time for effective intervention. This leads to increased complications (muscle necrosis/amputation) and costs the US healthcare system more than $2.25 B annually. MY01 is capitalizing on a proven correlation between sustained increase in Intramuscular pressures and ACS for objective, early diagnosis. MY01 operationalizes muscular pressure monitoring into a simple, accurate single-use device. MY01. The simple solution to a dangerous problem.
The West Wireless Health Institute is one of the first medical research organizations in the world supporting the exploration and application of wireless technologies to advance infrastructure independent health care.
WHILL was started by a group of automotive, consumer electronics, and medical device designers and engineers who dreamed of pushing the boundaries of pedestrian transportation for everyone, especially for those who have difficulty walking.
At ReSound, people with hearing loss are at the heart of everything we do. We think big and challenge the norm, because we believe Smart Hearing has the power to transform lives. Our award-winning Smart Hearing aids help people feel more involved, connected and in control. They deliver the best sound quality and optimal design. Smart Hearing aids also work like wireless stereo headphones, streaming sound directly to the hearing aids from devices like an iPhone® or a TV. An accompanying app gives full control and the ability to personalize each hearing experience. ReSound hearing aids are exclusively available through hearing care professionals, who adjust them to each individual`s specific hearing loss. With research teams in USA and Holland, we are headquartered in Denmark. ReSound is part of the GN Group, pioneering great sound from world leading ReSound hearing aids to Jabra office headsets and sports headphones. Founded in 1869, building on a strong legacy of innovative audio and communications solutuions, and listed on NSDAQ OMX Copenhagen, GN makes life sound better.